Investment firm Tang Capital has acquired a 10% stake in pharmaceutical company Aurinia Pharma. The move signals Tang Capital's interest and commitment to the sector.
This stake acquisition by Tang Capital indicates a significant investment and potential strategic interest in Aurinia Pharma and the broader pharmaceutical sector.
Tang Capital has acquired a 10% stake in Aurinia Pharma. This investment represents a notable move by Tang Capital within the pharmaceutical industry, signaling its interest and commitment to the sector.